uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Business Models of European SMEs in Antibacterial R&D: Challenges and Impact of Incentive Solutions
Uppsala University, Disciplinary Domain of Science and Technology, Technology, Department of Engineering Sciences.
2017 (English)Independent thesis Advanced level (degree of Master (One Year)), 10 credits / 15 HE creditsStudent thesis
Abstract [en]

Currently, antibacterial research and development (R&D) is faced with market failure as

competitive market forces fail to produce the best outcome for the society. The society

urgently needs novel antibiotics to combat the serious public health threat of growing

antibacterial resistance, but adverse economic environment in the market discourages

investment, resulting in dry development pipelines. With only few large pharmaceutical

companies remaining in the field, small to medium sized firms (SMEs) are playing an

increasingly important role in antibacterial innovation. Global efforts to reinvigorate the

pipeline are underway with initiatives like DRIVE-AB to propose new economic models

of incentives to attract investment. This study investigates the current business models

of European SMEs in antibacterial R&D, and the challenges they face operating under

these models. This study also assesses the impact of two incentive mechanisms – grants

and market entry reward on the business models of SMEs and generates predicted

business models after implementation of incentives, in order to guide policymaking. The

business models are built upon interview with DRIVE-AB member and secondary

qualitative and quantitative data collected for DRIVE-AB project. The predicted business

models show that incentives such as grants and market entry reward can help repair the

currently broken business models of SMEs by stimulating investment and encouraging

participation, in hopes of reinvigorating the pipeline.

Place, publisher, year, edition, pages
2017. , p. 52
Series
TVE-MILI ; 17 008
Keywords [en]
Antibacterial R&D, Business Models, Antibiotics, SMEs, Incentives, Market Entry Reward, Grants
National Category
Business Administration
Identifiers
URN: urn:nbn:se:uu:diva-325966OAI: oai:DiVA.org:uu-325966DiVA, id: diva2:1117856
Educational program
Master Programme in Industrial Management and Innovation
Presentation
2017-06-15, Ind Tek, Ångström Lab, Uppsala University, 10:00 (English)
Supervisors
Examiners
Projects
DRIVE-ABAvailable from: 2017-06-30 Created: 2017-06-29 Last updated: 2017-06-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Department of Engineering Sciences
Business Administration

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 249 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf